Literature DB >> 36099133

Quantitative Analysis of Diffusion Weighted Imaging May Improve Risk Stratification of Prostatic Transition Zone Lesions.

Hannes Engel1, Benedict Oerther2, Marco Reisert3, Elias Kellner3, August Sigle4, Christian Gratzke4, Peter Bronsert5,6, Tobias Krauss2, Fabian Bamberg2, Matthias Benndorf2.   

Abstract

BACKGROUND/AIM: To investigate whether quantitative analysis of diffusion weighted images allows for improved risk stratification of transition zone lesions in prostate magnetic resonance imaging (MRI) evaluated according to PI-RADSv2.1 [Prostate Imaging Reporting and Data System, target variable: clinically significant prostate cancer (csPCa)]. PATIENTS AND METHODS: Consecutive patients with transition zone lesions in 3T prostate MRI were enrolled in the study. All lesions on MRI were histopathologically verified by transperineal MRI-TRUS fusion biopsy. Two blinded radiologists re-evaluated all lesions according to PI-RADSv2.1. A consensus reading was performed after reading of all cases. Additionally, mean apparent diffusion coefficient values (mADC) were derived from blinded lesion segmentation. ROC analysis was performed for PI-RADS categories and PI-RADS categories with separate subcategories and diffusion coefficient values (ADC). Data were examined for optimal mADC cut-off values that improve stratification of csPCa and benign lesions.
RESULTS: Among 85 patients (mean age=66.2 years), 98 transition zone lesions were detected. Biopsy confirmed csPCa in 24/98 cases. Area under the curve (AUC) was 0.89/0.90 for reader 1, 0.92/0.91 for reader 2 and 0.92/0.91 for the consensus reading (5 category analysis/analysis with subcategories separately). Inter-reader agreement was substantial, with lower PI-RADS categories assigned by the more experienced reader (p<0.05). AUC for mADC alone was 0.81. When a cut-off threshold of 950 μm2/s mADC is used to downgrade PI-RADS 3 lesions to PI-RADS 2, biopsy could be avoided in all benign PI-RADS 3 cases.
CONCLUSION: Quantitative analysis of diffusion weighted images may help avoid unnecessary biopsies of transition zone PI-RADS 3 lesions.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  ADC; DWI; MRI; PI-RADS; Prostate cancer; diffusion weighted imaging; transition zone

Mesh:

Year:  2022        PMID: 36099133      PMCID: PMC9463894          DOI: 10.21873/invivo.12963

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.406


  25 in total

1.  Comparison of apparent diffusion coefficient values among different MRI platforms: a multicenter phantom study.

Authors:  Ali Sami Kıvrak; Yahya Paksoy; Cengiz Erol; Mustafa Koplay; Seda Özbek; Fatih Kara
Journal:  Diagn Interv Radiol       Date:  2013 Nov-Dec       Impact factor: 2.630

2.  Early detection of prostate cancer: AUA Guideline.

Authors:  H Ballentine Carter; Peter C Albertsen; Michael J Barry; Ruth Etzioni; Stephen J Freedland; Kirsten Lynn Greene; Lars Holmberg; Philip Kantoff; Badrinath R Konety; Mohammad Hassan Murad; David F Penson; Anthony L Zietman
Journal:  J Urol       Date:  2013-05-06       Impact factor: 7.450

3.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

4.  PI-RADS Versions 2 and 2.1: Interobserver Agreement and Diagnostic Performance in Peripheral and Transition Zone Lesions Among Six Radiologists.

Authors:  Rajesh Bhayana; Aileen O'Shea; Mark A Anderson; William R Bradley; Ravi V Gottumukkala; Amirkasra Mojtahed; Theodore T Pierce; Mukesh Harisinghani
Journal:  AJR Am J Roentgenol       Date:  2020-09-09       Impact factor: 3.959

5.  MR Fingerprinting and ADC Mapping for Characterization of Lesions in the Transition Zone of the Prostate Gland.

Authors:  Ananya Panda; Verena C Obmann; Wei-Ching Lo; Seunghee Margevicius; Yun Jiang; Mark Schluchter; Indravadan J Patel; Dean Nakamoto; Chaitra Badve; Mark A Griswold; Irina Jaeger; Lee E Ponsky; Vikas Gulani
Journal:  Radiology       Date:  2019-07-23       Impact factor: 11.105

6.  Transition zone prostate cancer: Logistic regression and machine-learning models of quantitative ADC, shape and texture features are highly accurate for diagnosis.

Authors:  Mark Wu; Satheesh Krishna; Rebecca E Thornhill; Trevor A Flood; Matthew D F McInnes; Nicola Schieda
Journal:  J Magn Reson Imaging       Date:  2019-01-30       Impact factor: 4.813

7.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.

Authors:  Nicolas Mottet; Joaquim Bellmunt; Michel Bolla; Erik Briers; Marcus G Cumberbatch; Maria De Santis; Nicola Fossati; Tobias Gross; Ann M Henry; Steven Joniau; Thomas B Lam; Malcolm D Mason; Vsevolod B Matveev; Paul C Moldovan; Roderick C N van den Bergh; Thomas Van den Broeck; Henk G van der Poel; Theo H van der Kwast; Olivier Rouvière; Ivo G Schoots; Thomas Wiegel; Philip Cornford
Journal:  Eur Urol       Date:  2016-08-25       Impact factor: 20.096

8.  Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?

Authors:  Ely R Felker; Steven S Raman; Daniel J Margolis; David S K Lu; Nicholas Shaheen; Shyam Natarajan; Devi Sharma; Jiaoti Huang; Fred Dorey; Leonard S Marks
Journal:  AJR Am J Roentgenol       Date:  2017-08-31       Impact factor: 3.959

9.  Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters.

Authors:  Piotr Woźnicki; Niklas Westhoff; Thomas Huber; Philipp Riffel; Matthias F Froelich; Eva Gresser; Jost von Hardenberg; Alexander Mühlberg; Maurice Stephan Michel; Stefan O Schoenberg; Dominik Nörenberg
Journal:  Cancers (Basel)       Date:  2020-07-02       Impact factor: 6.639

10.  The Role of PSA Density among PI-RADS v2.1 Categories to Avoid an Unnecessary Transition Zone Biopsy in Patients with PSA 4-20 ng/mL.

Authors:  Zhi-Bing Wang; Chao-Gang Wei; Yue-Yue Zhang; Peng Pan; Guang-Cheng Dai; Jian Tu; Jun-Kang Shen
Journal:  Biomed Res Int       Date:  2021-10-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.